Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer

Published:2018-09-11 Issue:3 Volume:172 Page:725-732
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Pérez-Peña Javier,Győrffy Balázs,Amir Eitan,Pandiella Atanasio,Ocaña Alberto^ORCID

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

ACEPAIN

Diputación Provincial de Albacete

CRIS Cancer Foundation

CIBERONC

Fundación Científica Asociación Española Contra el Cáncer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4965-x/fulltext.html

Reference27 articles.

1. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339(6127):1546–1558

2. Ocana A, Pandiella A (2010) Personalized therapies in the cancer “omics” era. Mol Cancer 9:202

3. Ocana A, Pandiella A, Siu LL, Tannock IF (2010) Preclinical development of molecular-targeted agents for cancer. Nat Rev Clin Oncol 8:200–209

4. Ocana A, Serrano R, Calero R, Pandiella A (2009) Novel tyrosine kinase inhibitors in the treatment of cancer. Curr Drug Targets 10(6):575–576

5. Ocana A, Nieto-Jimenez C, Pandiella A (2017) BET inhibitors as novel therapeutic agents in breast cancer. OncoTarget 8(41):71285–71291

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity;Frontiers in Pharmacology;2023-11-30

2. Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers;Cancers;2022-09-15

3. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner;Cell & Bioscience;2022-02-23

4. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE;Biochemical Pharmacology;2020-10

5. The emerging role of BET inhibitors in breast cancer;The Breast;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3